News for 'LED DRL'

TVS Orbiter: Big on range, short on hill climb

TVS Orbiter: Big on range, short on hill climb

Rediff.com12 Feb 2026

The TVS Orbiter works best as a city scooter with good range and comfort, but it quickly runs out of steam on steep climbs.

'14+ Anti-Obesity Drugs In The Pipeline'

'14+ Anti-Obesity Drugs In The Pipeline'

Rediff.com13 Dec 2025

The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.

VinFast disrupts EV market with most affordable midsize SUV

VinFast disrupts EV market with most affordable midsize SUV

Rediff.com1 Oct 2025

VinFast's VF6 storms into India as the most affordable electric SUV above 4 metres, packing premium features, 468km range, and free charging till 2028 to disrupt the EV market, observes Somnath Chatterjee.

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Dr Reddy's faces Revlimid cliff, analysts split on future growth prospects

Rediff.com26 Jan 2025

Dr Reddy's Laboratories (DRL) share price plunged 6.66 per cent to Rs 1,203.50 per share on the NSE during Friday after analysts remained cautious on the company's Q3 performance and differed on its growth outlook. DRL's Q3 performance was viewed as subdued by some analysts when they adjusted it for one-time grants and incomes that the company received during the quarter.

Does BGauss RUV 350 Pack A Punch?

Does BGauss RUV 350 Pack A Punch?

Rediff.com28 Jun 2024

Overall, the BGauss RUV 350 is a feature-packed electric scooter with a unique design and competitive performance.

Cipla on the block: Who's a better fit and what it means for shareholders?

Cipla on the block: Who's a better fit and what it means for shareholders?

Rediff.com21 Sep 2023

India's third-largest pharmaceutical company by revenue, Cipla, is up for grabs in a three-way fight between Torrent Pharmaceuticals, Dr Reddy's Laboratories (DRL) and private equity (PE) giant Blackstone. Analysts say it is more likely for a strategic investor like Torrent or DRL to acquire Cipla than a PE firm, which may not derive healthy returns at Cipla's current market price (CMP) after the recent gains.

US drug shortage, stable pricing set to boost pharma revenues

US drug shortage, stable pricing set to boost pharma revenues

Rediff.com24 Jul 2023

An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India's pharmaceutical companies during the first quarter of this financial year, analysts said. Most brokerages estimate a top line growth of around 14-15 per cent, with earnings before interest, taxes, depreciation, and amortisation (Ebitda) growth of 24-30 per cent for Q1 of FY24. Hospitals are, however, likely to report lower occupancy rates, and diagnostics companies may witness an impact from delayed monsoon.

Will you buy the Suzuki Intruder 150 for Rs 98k?

Will you buy the Suzuki Intruder 150 for Rs 98k?

Rediff.com17 Nov 2017

The bike ticks all the right boxes when it comes to style, handling and riding dynamic.

Mercedes-Benz S-Class gets a facelift

Mercedes-Benz S-Class gets a facelift

Rediff.com30 Mar 2018

New Mercedes-Benz S-Class gets a power lift and cosmetic changes, says Joshua David Luther.

The New Age XUV500: An absolute beast for SUV lovers

The New Age XUV500: An absolute beast for SUV lovers

Rediff.com5 Jun 2015

The new age XUV500 is the most valuable product from Mahindra

'Cipla has emerged as a great catchment area for talent'

'Cipla has emerged as a great "catchment area" for talent'

Rediff.com20 Aug 2020

An insider said that over the past decade or so Cipla has become immune to the exits of leaders. There have been no directional change in the long-term strategies.

Wow! What a head turner!

Wow! What a head turner!

Rediff.com30 Mar 2015

The KTM RC 390 will make heads turn while you clock triple digit speed on open roads or preferably on a race track, where it will feel at home. Priced at Rs 2,37,790 (on-road, Mumbai), there is nothing at this price point which comes close to the RC 390 offering on par or even close performance, says Faisal Ali Khan of MotorBeam.com.

India Inc braces for fallout of Russia-Ukraine crisis

India Inc braces for fallout of Russia-Ukraine crisis

Rediff.com23 Feb 2022

Stocks of Indian companies with exposure to Europe fell on Tuesday amid concerns about the impact on their sales in case the Russia-Ukraine crisis worsens and the US and its allies impose economic sanctions on Russia. While top conglomerates, including Reliance Industries, the Tata group, and Aditya Birla Group, said they did not have any significant exposure to Russia, executives of some of the oil and gas, pharmaceutical, and tea companies said they were monitoring the situation closely as they earned substantial income from the region. Russian President Vladimir Putin on Monday ordered troops into two breakaway regions of eastern Ukraine after announcing that Russia would recognise their independence.

Dr Reddy's Labs sees downswing

Dr Reddy's Labs sees downswing

Rediff.com12 Apr 2003

In the cataclysmic fall by techs led by Infosys, the sudden downturn by Dr Reddy's Labs late Friday went virtually innoticed.

Wow: The head-turners at Auto Expo 2018

Wow: The head-turners at Auto Expo 2018

Rediff.com8 Feb 2018

These bikes were all the craze on Day 1 of Auto Expo 2018's media exclusive.

TVS Apache RTR 200 4V: What's hot, what's not!

TVS Apache RTR 200 4V: What's hot, what's not!

Rediff.com1 Oct 2016

Known for their brisk performance, sweet handling and strong styling cues, TVS has now introduced the much awaited 200cc flagship. Tanmay Pangam takes it for a spin.

How Indian pharma bounced back from lockdown lows

How Indian pharma bounced back from lockdown lows

Rediff.com7 Dec 2020

From rising prescriptions to the pharma sales force back on the field with full vigour and companies finally finding their feet with the digital marketing strategies - Indian drug makers have shown that medicine sales is certainly a sunshine sector.

Is Ducati Panigale V4 the undisputed king of superbikes?

Is Ducati Panigale V4 the undisputed king of superbikes?

Rediff.com4 Apr 2018

The new Panigale V4 S' sheer performance, dynamic ability and the ease with which it is delivered leaves one in no doubt about the absolute punch that this motorcycle packs.

Predator on the prowl!

Predator on the prowl!

Rediff.com25 Nov 2015

Unconventional and still quirky looking as ever, the Mojo gets me thinking of the Predator (from the Arnold Schwarzenegger classic) with hints of Yamah's (bug-eyed) 125cc Fazer and Triumph's Street Triple to stir things up.

Markets ends at highest level since Jan 2011

Markets ends at highest level since Jan 2011

Rediff.com15 May 2013

Bank Nifty closes at a 30-month high; Rate sensitives lead the rally on RBI rate cut optimism.

NTORQ 125: India's most feature-loaded scooter is here

NTORQ 125: India's most feature-loaded scooter is here

Rediff.com29 Mar 2018

Be it performance, styling, features, refinement and price, the NTORQ ticks all the boxes, says Rajesh Alva.